159 related articles for article (PubMed ID: 20219786)
1. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Plant D; Thomson W; Lunt M; Flynn E; Martin P; Eyre S; Farragher T; Bunn D; Worthington J; Symmons D; Barton A
Rheumatology (Oxford); 2011 Jan; 50(1):78-84. PubMed ID: 20219786
[TBL] [Abstract][Full Text] [Related]
2. Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage.
Viatte S; Plant D; Lunt M; Fu B; Flynn E; Parker BJ; Galloway J; Solymossy C; Worthington J; Symmons DP; Dixey JJ; Young A; Barton A
J Rheumatol; 2013 Feb; 40(2):144-56. PubMed ID: 23242182
[TBL] [Abstract][Full Text] [Related]
3. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis.
Barton A; Bowes J; Eyre S; Symmons D; Worthington J; Silman A
Ann Rheum Dis; 2005 Sep; 64(9):1311-5. PubMed ID: 15731287
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis.
Barton A; Platt H; Salway F; Symmons D; Lunt M; Worthington J; Silman A
J Rheumatol; 2004 Mar; 31(3):442-7. PubMed ID: 14994386
[TBL] [Abstract][Full Text] [Related]
5. A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.
van Steenbergen HW; Rodríguez-Rodríguez L; Berglin E; Zhernakova A; Knevel R; Ivorra-Cortés J; Huizinga TW; Fernández-Gutiérrez B; Gregersen PK; Rantapää-Dahlqvist S; van der Helm-van Mil AH
Arthritis Res Ther; 2015 Jan; 17(1):1. PubMed ID: 25566937
[TBL] [Abstract][Full Text] [Related]
6. The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome.
Naseem H; Thomson W; Silman A; Worthington J; Symmons D; Barton A
Ann Rheum Dis; 2008 Feb; 67(2):251-5. PubMed ID: 17666450
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory Polyarthritis.
Ling SF; Viatte S; Lunt M; Van Sijl AM; Silva-Fernandez L; Symmons DP; Young A; Macgregor AJ; Barton A
Arthritis Rheumatol; 2016 Nov; 68(11):2618-2628. PubMed ID: 27274008
[TBL] [Abstract][Full Text] [Related]
8. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
Kurreeman FA; Padyukov L; Marques RB; Schrodi SJ; Seddighzadeh M; Stoeken-Rijsbergen G; van der Helm-van Mil AH; Allaart CF; Verduyn W; Houwing-Duistermaat J; Alfredsson L; Begovich AB; Klareskog L; Huizinga TW; Toes RE
PLoS Med; 2007 Sep; 4(9):e278. PubMed ID: 17880261
[TBL] [Abstract][Full Text] [Related]
9. Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients.
Farragher TM; Plant D; Flynn E; Eyre S; Bunn D; Thomson W; Symmons D; Barton A
Arthritis Care Res (Hoboken); 2010 May; 62(5):676-82. PubMed ID: 20461788
[TBL] [Abstract][Full Text] [Related]
10. Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?
Scott IC; Rijsdijk F; Walker J; Quist J; Spain SL; Tan R; Steer S; Okada Y; Raychaudhuri S; Cope AP; Lewis CM
J Rheumatol; 2015 Jul; 42(7):1131-40. PubMed ID: 25979711
[TBL] [Abstract][Full Text] [Related]
11. Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary care-based inception cohort of patients.
Bukhari M; Lunt M; Harrison BJ; Scott DG; Symmons DP; Silman AJ
Rheumatology (Oxford); 2002 Mar; 41(3):246-52. PubMed ID: 11934959
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.
Patsopoulos NA; Ioannidis JP
Ann Rheum Dis; 2010 Mar; 69(3):561-6. PubMed ID: 19401279
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis.
Barton A; Platt H; Salway F; Symmons D; Barrett E; Bukhari M; Lunt M; Zeggini E; Eyre S; Hinks A; Tellam D; Brintnell B; Ollier W; Worthington J; Silman A
Ann Rheum Dis; 2004 Mar; 63(3):280-4. PubMed ID: 14962963
[TBL] [Abstract][Full Text] [Related]
15. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A
J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
[TBL] [Abstract][Full Text] [Related]
16. Has the severity of rheumatoid arthritis at presentation diminished over time?
Diffin JG; Lunt M; Marshall T; Chipping JR; Symmons DP; Verstappen SM
J Rheumatol; 2014 Aug; 41(8):1590-9. PubMed ID: 24986850
[TBL] [Abstract][Full Text] [Related]
17. A genetic marker at the OLIG3/TNFAIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Plant D; Farragher T; Flynn E; Martin P; Eyre S; Bunn D; Worthington J; Symmons D; Barton A; Thomson W
Pharmacogenomics J; 2012 Apr; 12(2):128-33. PubMed ID: 20921970
[TBL] [Abstract][Full Text] [Related]
18. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.
Stockman A; Tait BD; Wolfe R; Brand CA; Rowley MJ; Varney MD; Buchbinder R; Muirden KD
Rheumatol Int; 2006 Apr; 26(6):500-9. PubMed ID: 16151812
[TBL] [Abstract][Full Text] [Related]
19. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
[TBL] [Abstract][Full Text] [Related]
20. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
Plenge RM; Seielstad M; Padyukov L; Lee AT; Remmers EF; Ding B; Liew A; Khalili H; Chandrasekaran A; Davies LR; Li W; Tan AK; Bonnard C; Ong RT; Thalamuthu A; Pettersson S; Liu C; Tian C; Chen WV; Carulli JP; Beckman EM; Altshuler D; Alfredsson L; Criswell LA; Amos CI; Seldin MF; Kastner DL; Klareskog L; Gregersen PK
N Engl J Med; 2007 Sep; 357(12):1199-209. PubMed ID: 17804836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
